Non-compliance with the re-excision guidelines for cutaneous melanoma in The Netherlands does not influence survival

European Journal of Surgical Oncology

Volumn 32, Issue 1, 2006, Pages 85-89

  Haniff, J ^a   de Vries, E ^a   Claassen, A T P M ^b   Looman, C W N ^a   van Berlo, Ch ^c,d   Coebergh, J W W ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TWENTEBORG HOSPITAL   (Netherlands)

^c The Netherlands   (Netherlands)

^d VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

Compliance; Cutaneous melanoma; Guideline; Re excision; Survival

Indexed keywords

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; NETHERLANDS; POPULATION DISTRIBUTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; RETROSPECTIVE STUDY; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

AGE FACTORS; CLINICAL COMPETENCE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PRACTICE GUIDELINES; REOPERATION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 30844438282     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.09.009     Document Type: Article

References (23)

1. L.D. Marrett H.L. Nguyen B.K. Armstrong Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996 Int J Cancer 92 2001 457-462
2. A. Jemal S.S. Devesa P. Hartge M.A. Tucker Recent trends in cutaneous melanoma incidence among whites in the United States J Natl Cancer Inst 93 2001 678-683
3. M. Thorn F. Ponten R. Bergstrom P. Sparen H.O. Adami Clinical and histopathologic predictors of survival in patients with malignant melanoma: A population-based study in Sweden J Natl Cancer Inst 86 1994 761-769
4. R.M. MacKie D. Hole J.A. et al. Hunter Cutaneous malignant melanoma in Scotland: Incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group BMJ 315 1997 1117-1121
5. E. de Vries F. Bray J.W.W. Coebergh D.M. Parkin ENCR Changing epidemiology of malignant cutaneous melanoma in Europe 1969-1997: Rising trends in incidence and mortality, but recent stabilisations in Western Europe and decreases in Scandinavia Int J Cancer 107 2003 119-126
6. E. de Vries L.V. van de Poll-Franse W.J. Louwman F.R. de Gruijl J.W. Coebergh Predictions of skin cancer incidence in The Netherlands up to 2015 Br J Dermatol 152 2005 481-488
7. Coebergh JW, Van Leer EM, Alers JC, De Gruiji FR, Vander Kluijt-Dijken CAL, Van der Rhee HJ et al. Ultraviolette straling en huidkanker. Oisterwijk: Nederlandse Kankerbestrijding/Koningin Wilhelmina Fonds; 2002 [Report no. 90-71229-10-6].
8. IKC net. http://www.ikcnet.nl/; 2004.
9. J. Coebergh M. Janssen-Heijnen W. Louwman A. Voogd Cancer incidence, care and survival in the south of The Netherlands, 1955-1999: A report from the Eindhoven Cancer Registry (IKZ) with cross-border implications 2001 Comprehensive Cancer Centre South (IKZ) Eindhoven
10. C.M. Balch S.J. Soong G.W. Milton H.M. Shaw V.J. McGovern W.H. McCarthy et al. Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia Cancer 52 1983 1748-1753
11. Nederlandse Richtlijn melanoom van de huid. Vereniging van Integrale Kankercentra; utrecht, 1997.
12. A.T. Claassen C.L. Van Berlo J.W. Coebergh Melanoma of the skin: excision policy and pathology report writing in the 'Integraal Kankercentrum Zuid' region is in accordance with the guideline in slightly more than half of the patients. Melanoom van de huid: excisiebeleid en pathologieverslaglegging in de regio van het Integraal Kankercentrum Zuid bij iets meer dan de helft van de patienten volgens de richtlijn Ned Tijdschr Geneeskd 145 2001 2079-2083
13. K.F. Kolmel B. Kulle A. Lippold C. Seebacher Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy Eur J Cancer 38 2002 1388-1394
14. C.M. Balch S.J. Soong J.E. Gershenwald J.F. Thompson D.S. Reintgen N Cascinelli et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 2001 3622-3634
15. P.J. Heenan L.L. Yu D.R. English Cutaneous malignant melanoma M.K. Gospodarowicz Prognostic factors in cancer 2001 Wiley-Liss Inc. New York
16. G. Cohn-Cedermark E. Mansson-Brahme L.E. Rutqvist O. Larsson T. Singnomklao U. Ringborg Outcomes of patients with local recurrence of cutaneous malignant melanoma: A population-based study Cancer 80 1997 1418-1425
17. C.L. Day Jr R.A. Lew Malignant melanoma prognostic factors 3: Surgical margins J Dermatol Surg Oncol 9 1983 797-801
18. M.G. O'Rourke C.R. Altmann Melanoma recurrence after excision. Is a wide margin justified? Ann Surg 217 1993 2-5
19. D.L. Roberts A.V. Anstey R.J. Barlow et al. U.K. guidelines for the management of cutaneous melanoma Br J Dermatol 146 2002 7-17
20. L. Brochez E. Verhaeghe F. Sales et al. Current guidelines in melanoma treatment. Melanoma Working Group of Gent and Bordet Dermatology 200 2000 160-166
21. R. Dummer U. Bosch R. Panizzon P.H. Bloch G. Burg Swiss guidelines for the treatment and follow-up of cutaneous melanoma Dermatology 203 2001 75-80
22. C.M. Balch M.M. Urist C.P. Karakousis et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial Ann Surg 218 1993 262-267
23. U. Veronesi N. Cascinelli J. Adamus et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm N Engl J Med 318 1988 1159-1162